CAPR: Capricor Therapeutics, Inc.
About
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Current Value
$17.941 Year Return
Current Value
$17.941 Year Return
Key Details
Market Cap
$808.91M
P/E Ratio
-16.75
1Y Stock Return
496.98%
1Y Revenue Growth
65.33%
Dividend Yield
0.00%
Price to Book
10.5
Strategies that include CAPR
Stock's related to CAPR
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LBRDA | 36.42% | $12.27B | +3.03% | 0.00% |
| TIGR | 36.13% | $845.65M | +17.40% | 0.00% |
| TECX | 28.48% | $662.25M | +194.55% | 0.00% |
| ZCMD | 28.10% | $2.67M | -88.95% | 0.00% |
| TTEC | 26.82% | $229.58M | -73.96% | 1.25% |
| WB | 26.24% | $1.39B | -17.77% | 0.00% |
| CPRI | 26.10% | $2.32B | -59.72% | 0.00% |
| FCX | 26.03% | $62.88B | +19.01% | 1.03% |
| CORT | 26.00% | $5.86B | +120.68% | 0.00% |
| MP | 25.87% | $3.06B | +16.77% | 0.00% |
| ATUS | 25.60% | $1.19B | +12.61% | 0.00% |
| NOAH | 25.04% | $778.53M | -2.34% | 9.10% |
| ZTO | 24.53% | $11.85B | -10.80% | 4.98% |
| SNDX | 23.85% | $1.33B | +1.56% | 0.00% |
| IQ | 23.67% | $1.06B | -57.47% | 0.00% |
| FUTU | 23.61% | $7.92B | +42.62% | 0.00% |
| SMG | 23.47% | $4.35B | +36.09% | 3.47% |
| SOL | 23.33% | $96.00M | -20.18% | 0.00% |
| CE | 23.00% | $8.20B | -43.06% | 3.72% |
| MGRC | 22.92% | $2.93B | +20.02% | 1.58% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NKE | <0.01% | $111.79B | -30.41% | 1.94% |
| PRTA | 0.01% | $777.00M | -55.88% | 0.00% |
| KEX | 0.01% | $7.39B | +66.77% | 0.00% |
| AL | 0.01% | $5.55B | +30.03% | 1.69% |
| CDRE | -0.02% | $1.33B | +2.50% | 1.07% |
| AAP | -0.02% | $2.31B | -26.43% | 2.58% |
| JNPR | -0.03% | $11.73B | +31.03% | 2.48% |
| AMSF | 0.05% | $1.11B | +21.09% | 2.48% |
| SMMT | 0.06% | $13.58B | +844.62% | 0.00% |
| ADNT | -0.06% | $1.66B | -40.57% | 0.00% |
| VSAT | -0.06% | $1.07B | -58.52% | 0.00% |
| KOP | -0.06% | $765.76M | -10.81% | 0.71% |
| AJX | 0.08% | $136.26M | -35.06% | 9.36% |
| MCO | -0.09% | $86.60B | +31.10% | 0.69% |
| GGG | -0.09% | $15.13B | +10.97% | 1.13% |
| ALV | 0.10% | $7.70B | -3.81% | 2.77% |
| NSP | 0.12% | $2.76B | -34.94% | 3.15% |
| ORKA | 0.12% | $717.47M | +69.86% | 0.00% |
| AQB | 0.13% | $3.75M | -53.98% | 0.00% |
| MOV | -0.14% | $423.77M | -33.25% | 7.27% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LNW | -22.67% | $8.34B | +8.03% | 0.00% |
| MCK | -15.60% | $79.75B | +37.34% | 0.41% |
| NAPA | -15.35% | $1.63B | +6.56% | 0.00% |
| SRRK | -14.51% | $2.50B | +135.39% | 0.00% |
| LVO | -14.33% | $79.50M | -18.53% | 0.00% |
| OXBR | -13.81% | $19.24M | +183.49% | 0.00% |
| V | -12.85% | $591.57B | +22.14% | 0.70% |
| STLA | -12.15% | $37.05B | -36.20% | 12.91% |
| TAK | -11.59% | $42.26B | -4.79% | 2.19% |
| GPCR | -11.13% | $1.72B | -41.41% | 0.00% |
| SEG | -10.46% | $344.46M | +21.11% | 0.00% |
| VHC | -10.24% | $18.68M | -40.78% | 0.00% |
| SYPR | -9.99% | $32.23M | -26.70% | 0.00% |
| HIHO | -9.02% | $8.50M | -1.53% | 6.22% |
| SKM | -8.81% | $8.68B | +1.66% | 6.26% |
| OCX | -8.69% | $44.95M | -32.75% | 0.00% |
| PARR | -8.56% | $971.89M | -50.54% | 0.00% |
| TLPH | -8.36% | $11.91M | +9.27% | 0.00% |
| GAN | -8.30% | $82.94M | +20.53% | 0.00% |
| GPN | -8.25% | $29.61B | +3.51% | 0.86% |
ETF's related to CAPR
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TBLL | 26.73% | $1.92B | 0.08% |
| DEM | 25.67% | $2.79B | 0.63% |
| BCD | 23.56% | $245.10M | 0.3% |
| EEMV | 23.29% | $4.16B | 0.25% |
| CMDY | 22.87% | $285.76M | 0.28% |
| LDEM | 22.69% | $30.92M | 0.17% |
| SCHE | 22.60% | $9.27B | 0.11% |
| INFL | 22.50% | $1.08B | 0.85% |
| FMAT | 22.17% | $558.67M | 0.084% |
| GEM | 22.15% | $942.99M | 0.45% |
| QVAL | 22.10% | $378.03M | 0.29% |
| XLB | 22.04% | $5.97B | 0.09% |
| SYLD | 21.98% | $1.29B | 0.59% |
| VAW | 21.95% | $3.02B | 0.1% |
| BCI | 21.83% | $1.20B | 0.26% |
| IGE | 21.76% | $645.02M | 0.41% |
| EMGF | 21.53% | $712.53M | 0.25% |
| ICOW | 21.49% | $1.24B | 0.65% |
| DFEV | 21.43% | $760.20M | 0.43% |
| EEM | 21.33% | $17.73B | 0.7% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TBIL | -0.01% | $4.39B | 0.15% |
| HYD | 0.09% | $3.19B | 0.32% |
| FTSD | -0.15% | $174.03M | 0.25% |
| EQLS | -0.41% | $8.88M | 1% |
| BILZ | 0.53% | $553.02M | 0.14% |
| ICSH | -0.59% | $5.55B | 0.08% |
| SPTS | 0.88% | $5.70B | 0.03% |
| VRIG | -0.97% | $1.09B | 0.3% |
| SMB | 1.10% | $266.92M | 0.07% |
| DUSB | -1.14% | $812.64M | 0.15% |
| FMB | 1.47% | $2.03B | 0.65% |
| BUXX | 1.48% | $166.76M | 0.25% |
| GOVZ | 1.52% | $317.56M | 0.1% |
| FLDR | 1.60% | $604.50M | 0.15% |
| HYMU | 1.65% | $235.43M | 0.35% |
| FLBL | 1.80% | $647.33M | 0.45% |
| IBTE | -1.86% | $1.67B | 0.07% |
| HIGH | -1.95% | $301.36M | 0.51% |
| IBD | -2.12% | $330.68M | 0.44% |
| IBTG | 2.17% | $1.49B | 0.07% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| HDRO | -19.17% | $164.26M | 0.3% |
| ULST | -12.59% | $535.66M | 0.2% |
| USDU | -11.98% | $201.83M | 0.5% |
| PREF | -10.39% | $1.01B | 0.55% |
| XHLF | -10.34% | $883.02M | 0.03% |
| UUP | -9.80% | $359.07M | 0.77% |
| FTSM | -9.73% | $6.07B | 0.45% |
| XBIL | -9.47% | $637.84M | 0.15% |
| VIXY | -9.25% | $195.31M | 0.85% |
| BTAL | -8.54% | $379.51M | 1.43% |
| JUCY | -8.38% | $325.31M | 0.6% |
| TAIL | -8.28% | $68.06M | 0.59% |
| XONE | -8.28% | $550.61M | 0.03% |
| YEAR | -8.20% | $1.14B | 0.25% |
| IVOL | -7.88% | $549.88M | 1.02% |
| SHV | -7.23% | $18.36B | 0.15% |
| USTB | -7.15% | $800.51M | 0.35% |
| SGOV | -7.12% | $27.69B | 0.09% |
| KMLM | -7.03% | $348.59M | 0.9% |
| UTWO | -6.97% | $442.66M | 0.15% |
News
Yahoo
Milestone represents a significant step forward in the development of deramiocel for the treatment of Duchenne muscular dystrophy in the European regionSAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the European Medicines Agency (EMA) has granted both Orphan Drug and Advanced Therapy Medicinal Product (ATMP) designation
Yahoo
We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a look at where Capricor Therapeutics, Inc. (NASDAQ:CAPR) stands against other best multibagger stocks. November has been an eventful month so far for the market as the Fed cut rates by a […]
Yahoo
Capricor Therapeutics ( NASDAQ:CAPR ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.26m (down 63% from...
Yahoo
Q3 2024 Capricor Therapeutics Inc Earnings Call
SeekingAlpha
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ETCompany ParticipantsA.J.
Yahoo
Capricor (CAPR) delivered earnings and revenue surprises of -11.76% and 43.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.